Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simon

Showing results (901-910 of 1,036) with videos related to

Pageof 104
Sort By:
Pharmacology, Biochemistry, and Behavior|March 1, 2006
Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behaviorCraig F Ferris, Shi-Fang Lu, Tara Messenger, et al.
Veterinary Microbiology|January 15, 2014
In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome virusesI Dobrescu, B Levast, K Lai, et al.
Neurosurgical Focus|September 2, 2015
Visualization of nerve fibers and their relationship to peripheral nerve tumors by diffusion tensor imagingTene A Cage, Esther L Yuh, Stephanie W Hou, et al.
Biomedical Materials (Bristol, England)|October 27, 2017
Effect of the scaffold microenvironment on cell polarizability and capacitance determined by probabilistic computationsBeatriz A Pazmino Betancourt, Stephen J Florczyk, Mylene Simon, et al.
Muscle & Nerve|May 31, 2017
Effects of hemodialysis on intraneural blood flow in end-stage kidney diseaseAdeniyi A Borire, Ria Arnold, Bruce A Pussell, et al.
Diabetes/Metabolism Research and Reviews|June 3, 2018
Correlation between markers of peripheral nerve function and structure in type 1 diabetesAdeniyi A Borire, Tushar Issar, Natalie C Kwai, et al.
International Journal of Cardiology|June 16, 2018
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibeTracey G Simon, Kathleen E Corey, Christopher P Cannon, et al.
The Psychiatric Quarterly|March 29, 2000
A look to the past, directions for the futureM P Quirk, G Simon, J Todd, et al.
Journal of Pharmaceutical Sciences|March 9, 2013
Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonistKarine M Fabio, Christophe D Guillon, Shi-Fang Lu, et al.
Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Pageof 104

Showing results (901-910 of 1,036) with videos related to

Sort By:
Pageof 104
Pharmacology, Biochemistry, and Behavior|March 1, 2006
Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behaviorCraig F Ferris, Shi-Fang Lu, Tara Messenger, et al.
Veterinary Microbiology|January 15, 2014
In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome virusesI Dobrescu, B Levast, K Lai, et al.
Neurosurgical Focus|September 2, 2015
Visualization of nerve fibers and their relationship to peripheral nerve tumors by diffusion tensor imagingTene A Cage, Esther L Yuh, Stephanie W Hou, et al.
Biomedical Materials (Bristol, England)|October 27, 2017
Effect of the scaffold microenvironment on cell polarizability and capacitance determined by probabilistic computationsBeatriz A Pazmino Betancourt, Stephen J Florczyk, Mylene Simon, et al.
Muscle & Nerve|May 31, 2017
Effects of hemodialysis on intraneural blood flow in end-stage kidney diseaseAdeniyi A Borire, Ria Arnold, Bruce A Pussell, et al.
Diabetes/Metabolism Research and Reviews|June 3, 2018
Correlation between markers of peripheral nerve function and structure in type 1 diabetesAdeniyi A Borire, Tushar Issar, Natalie C Kwai, et al.
International Journal of Cardiology|June 16, 2018
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibeTracey G Simon, Kathleen E Corey, Christopher P Cannon, et al.
The Psychiatric Quarterly|March 29, 2000
A look to the past, directions for the futureM P Quirk, G Simon, J Todd, et al.
Journal of Pharmaceutical Sciences|March 9, 2013
Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonistKarine M Fabio, Christophe D Guillon, Shi-Fang Lu, et al.
Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Pageof 104